Study of late toxicity biomarkers of locally advanced head and neck cancer patients treated with radiotherapy plus cisplatin or cetuximab points to the relevance of skin macrophages (TOX-TTCC-2015-01)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Study of late toxicity biomarkers of locally advanced head and neck cancer patients treated with radiotherapy plus cisplatin or cetuximab points to the relevance of skin macrophages (TOX-TTCC-2015-01) ; day:23 ; month:5 ; year:2024 ; pages:1-10
Clinical and translational oncology ; (23.5.2024), 1-10
- Urheber
-
Rullan, Antonio
Marín-Jiménez, Juan A.
Lozano, Alicia
Bermejo, Oriol
Arribas, Lorena
Ruiz, Nuria
Linares, Isabel
Taberna, Miren
Pérez, Xavi
Plana, María
Oliva, Marc
Mesía, Ricard
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12094-024-03526-0
- URN
-
urn:nbn:de:101:1-2408020956425.414858842450
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rullan, Antonio
- Marín-Jiménez, Juan A.
- Lozano, Alicia
- Bermejo, Oriol
- Arribas, Lorena
- Ruiz, Nuria
- Linares, Isabel
- Taberna, Miren
- Pérez, Xavi
- Plana, María
- Oliva, Marc
- Mesía, Ricard
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer
Primary chemoradiation with cisplatin versus cetuximab for locally advanced head and neck cancer: a retrospective cohort study
TOX
TOX
Comparing cisplatin-Chemoradiotherapy to Cetuximab-radiotherapy in HPV+ “low-risk” locally advanced oropharyngeal squamous cell carcinoma: lessons from De-escalate study
High efficacy of CpG-ODN, Cetuximab and Cisplatin combination for very advanced ovarian xenograft tumors
Survival, recurrence and toxicity of HNSCC in comparison of a radiotherapy combination with cisplatin versus cetuximab: a meta-analysis
Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m2 for definitive radiochemotherapy of locally advanced head-and-neck cancers
Comparative evaluation of concomitant chemoradiation with weekly cisplatin and gemcitabine versus weekly cisplatin in the management of locally advanced carcinoma of uterine cervix
TOX Bandit Shake
Mechanisms of neutralization of toxSAS from toxin–antitoxin modules
Recapitulating the Pharmacological Interactions of Cetuximab with Sunitinib and Cisplatin in Head and Neck Carcinoma Cells in vitro
Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer
Primary chemoradiation with cisplatin versus cetuximab for locally advanced head and neck cancer: a retrospective cohort study
TOX
TOX
Comparing cisplatin-Chemoradiotherapy to Cetuximab-radiotherapy in HPV+ “low-risk” locally advanced oropharyngeal squamous cell carcinoma: lessons from De-escalate study
High efficacy of CpG-ODN, Cetuximab and Cisplatin combination for very advanced ovarian xenograft tumors
Survival, recurrence and toxicity of HNSCC in comparison of a radiotherapy combination with cisplatin versus cetuximab: a meta-analysis
Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m2 for definitive radiochemotherapy of locally advanced head-and-neck cancers
Comparative evaluation of concomitant chemoradiation with weekly cisplatin and gemcitabine versus weekly cisplatin in the management of locally advanced carcinoma of uterine cervix
TOX Bandit Shake
Mechanisms of neutralization of toxSAS from toxin–antitoxin modules
Recapitulating the Pharmacological Interactions of Cetuximab with Sunitinib and Cisplatin in Head and Neck Carcinoma Cells in vitro
Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer
Primary chemoradiation with cisplatin versus cetuximab for locally advanced head and neck cancer: a retrospective cohort study
TOX
TOX
Comparing cisplatin-Chemoradiotherapy to Cetuximab-radiotherapy in HPV+ “low-risk” locally advanced oropharyngeal squamous cell carcinoma: lessons from De-escalate study
High efficacy of CpG-ODN, Cetuximab and Cisplatin combination for very advanced ovarian xenograft tumors
Survival, recurrence and toxicity of HNSCC in comparison of a radiotherapy combination with cisplatin versus cetuximab: a meta-analysis
Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m2 for definitive radiochemotherapy of locally advanced head-and-neck cancers
Comparative evaluation of concomitant chemoradiation with weekly cisplatin and gemcitabine versus weekly cisplatin in the management of locally advanced carcinoma of uterine cervix
TOX Bandit Shake
Mechanisms of neutralization of toxSAS from toxin–antitoxin modules